The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frauwirth, K. A.
Right arrow Articles by Thompson, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frauwirth, K. A.
Right arrow Articles by Thompson, C. B.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2001, 167: 4936-4941.
Copyright © 2001 by The American Association of Immunologists

CTLA-4 Is Not Required for Induction of CD8+ T Cell Anergy In Vivo1

Kenneth A. Frauwirth*, Maria-Luisa Alegre{dagger} and Craig B. Thompson2,*

* Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104; and {dagger} Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL, 60637

Recent studies of T cell anergy induction have produced conflicting conclusions as to the role of the negative regulatory receptor, CTLA-4. Several in vivo models of tolerance have implicated the interaction of CTLA-4 and its ligands, B7.1 and B7.2, as an essential step in induction of anergy, while results from a number of other systems have indicated that signals from the TCR/CD3 complex alone are sufficient to induce T cell unresponsiveness. One explanation for this disparity is that the requirements for anergy induction depend closely on the details of the system: in vivo vs in vitro, route of stimulus administration, naive vs memory cells, CD4+ vs CD8+ cells, etc. To test this possibility, we established an in vivo anergy model using mice transgenic for the 2C TCR on a recombination-activating gene-2-deficient background, that either express or lack the CTLA-4 molecule. This system provides us with a very homogeneous pool of naive Ag-specific CD8+ T cells, allowing us to control some of the conditions mentioned above. We found that T cells from CTLA-4-deficient mice were anergized by injections of soluble antigenic peptide as efficiently as were CTLA-4-expressing cells. These results indicate that CTLA-4 is not universally required for in vivo T cell anergy induction and may point to distinctions between regulation of peripheral tolerance in CD4+ and CD8+ T cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Chikuma, S. Terawaki, T. Hayashi, R. Nabeshima, T. Yoshida, S. Shibayama, T. Okazaki, and T. Honjo
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
J. Immunol., June 1, 2009; 182(11): 6682 - 6689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Dalai, S. Mirshahidi, A. Morrot, F. Zavala, and S. Sadegh-Nasseri
Anergy in Memory CD4+ T Cells Is Induced by B Cells
J. Immunol., September 1, 2008; 181(5): 3221 - 3231.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Srinivasan and K. A. Frauwirth
Reciprocal NFAT1 and NFAT2 Nuclear Localization in CD8+ Anergic T Cells Is Regulated by Suboptimal Calcium Signaling
J. Immunol., September 15, 2007; 179(6): 3734 - 3741.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Pandiyan, J. K. E. Hegel, M. Krueger, D. Quandt, and M. C. Brunner-Weinzierl
High IFN-{gamma} Production of Individual CD8 T Lymphocytes Is Controlled by CD152 (CTLA-4)
J. Immunol., February 15, 2007; 178(4): 2132 - 2140.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Gattinoni, A. Ranganathan, D. R. Surman, D. C. Palmer, P. A. Antony, M. R. Theoret, D. M. Heimann, S. A. Rosenberg, and N. P. Restifo
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent
Blood, December 1, 2006; 108(12): 3818 - 3823.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. E. Brown, C. Blank, J. Kline, A. K. Kacha, and T. F. Gajewski
Homeostatic Proliferation as an Isolated Variable Reverses CD8+ T Cell Anergy and Promotes Tumor Rejection
J. Immunol., October 1, 2006; 177(7): 4521 - 4529.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, S. Yu, D. Calida, Z. Zhao, B. Gran, M. Kamoun, and A. Rostami
Loss of the Surface Antigen 3G11 Characterizes a Distinct Population of Anergic/Regulatory T Cells in Experimental Autoimmune Encephalomyelitis
J. Immunol., March 15, 2006; 176(6): 3366 - 3373.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mukherjee, A. Ahmed, and D. Nandi
CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A
J. Leukoc. Biol., July 1, 2005; 78(1): 144 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Inobe and R. H. Schwartz
CTLA-4 Engagement Acts as a Brake on CD4+ T Cell Proliferation and Cytokine Production but Is Not Required for Tuning T Cell Reactivity in Adaptive Tolerance
J. Immunol., December 15, 2004; 173(12): 7239 - 7248.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. F. Rowley and A. Al-Shamkhani
Stimulation by Soluble CD70 Promotes Strong Primary and Secondary CD8+ Cytotoxic T Cell Responses In Vivo
J. Immunol., May 15, 2004; 172(10): 6039 - 6046.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. S. Vacchio and R. J. Hodes
CD28 Costimulation Is Required for In Vivo Induction of Peripheral Tolerance in CD8 T Cells
J. Exp. Med., January 6, 2003; 197(1): 19 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mukherjee, P. K. Maiti, and D. Nandi
Role of CD80, CD86, and CTLA4 on mouse CD4+ T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin
J. Leukoc. Biol., November 1, 2002; 72(5): 921 - 931.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh
Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size
J. Immunol., October 1, 2002; 169(7): 3744 - 3751.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. W. Hwang, W. B. Sweatt, I. E. Brown, C. Blank, T. F. Gajewski, J. A. Bluestone, and M.-L. Alegre
Cutting Edge: Targeted Ligation of CTLA-4 In Vivo by Membrane-Bound Anti-CTLA-4 Antibody Prevents Rejection of Allogeneic Cells
J. Immunol., July 15, 2002; 169(2): 633 - 637.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.